Log in with your email address username.

×

Attention doctorportal newsletter subscribers,

After December 2018, we will be moving elements from the doctorportal newsletter to MJA InSight newsletter and rebranding it to Insight+. If you’d like to continue to receive a newsletter covering the latest on research and perspectives in the medical industry, please subscribe to the Insight+ newsletter here.

As of January 2019, we will no longer be sending out the doctorportal email newsletter. The final issue of this newsletter will be distributed on 13 December 2018. Articles from this issue will be available to view online until 31 December 2018.

[Correspondence] Ocular gene therapy for neovascular AMD: a new era?

We read with great interest the study by Jeffrey S Heier and colleagues (July 1, p 50)1 on the beneficial effects of an intravitreal injection of AAV2-sFLT01 in patients with advanced neovascular age-related macular degeneration (AMD). Despite the original findings, there are methodological concerns that need to be further addressed.

email